New AstraZeneca drug that slashes Covid risk is approved - The Telegraph

One dose of Evusheld, which is given as two injections, has been found to reduce the risk of developing symptomatic disease by 77 per cent

The drug is a combination of two long-acting antibodies which bind to the spike protein on the outside of the virus, preventing it from attaching to and entering human cells. Dr June Raine, MHRA Chi… [+2489 chars]

full article...